[EN] RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE RAS, COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE CEUX-CI
申请人:[en]GENETOLEAD INC.
公开号:WO2023060362A1
公开(公告)日:2023-04-20
There is provided a compound of formula (I), and its use for inhibiting RAS (wild type or mutant), for example HRAS, NRAS, and/or KRAS, and for the prevention or treatment of a disease or disorder associated with abnormal RAS activity, for example abnormal RAS activity caused by a mutation in RAS, including cancers with a mutated RAS. (I)
Visible‐Light‐Induced Diradical‐Mediated
<i>ipso</i>
‐Cyclization towards Double Dearomative [2+2]‐Cycloaddition or Smiles‐Type Rearrangement
ipso-cyclization involving dearomatizing spiro-intermediates of aromatic compounds towards divergent reaction pathways deserves investigation but has been rarely reported so far. By tuning the rate of C−S bond cleavage in the key dearomatizing spiro intermediate, a chemical divergent reaction of (hetero)aryl sulfonamides has been achieved in a visible-light-induced energy transfer reaction pathway involving diradical